Related Experiment Video
Updated: Aug 19, 2025

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Is electronic cigarette use a risk factor for stroke? A systematic review and meta-analysis
Kai Zhao1, Jing Li2, Ping Zhou3
1Graduate School, Qinghai University, Xining, People's Republic of China.
Introduction:
Stroke, as a common cerebrovascular disease, has a high mortality and disability rate. Although many studies have reported that using e-cigarettes was associated with occurrence of stroke, some studies have concluded that e-cigarettes may help smokers stop using combustible cigarettes and reduce the risk of stroke. Therefore, we aimed to validate the hypothesis that e-cigarette use might be an independent risk factor for stroke occurrence by performing a systematic review and meta-analysis of clinical epidemiology studies.
Methods:
The pooled effect was calculated by the random effects model. I2 was used to test for heterogeneity. Sensitivity analysis was performed to evaluate the stability of the overall results. Funnel plot symmetry or Egger's regression was used to evaluate publication bias. All p values were two-sided with significance level at 0.05.
Results:
Six cross-sectional studies with high quality were finally included in the meta-analysis, which included a total of 1134896 participants. Analysis with random effects model showed that the total pooled odds ratio (OR) of stroke occurrence in e-cigarette users was 1.25 (95% CI: 1.01-1.55) (I2=96.6%, p<0.001). A stable result was revealed by sensitivity analysis. There was no publication bias. Due to high heterogeneity, we performed subgroup analysis. Compared to neither e-cigarette nor combustible cigarette users, pooled OR of stroke occurrence in e-cigarette only users was 1.13 (95% CI: 0.99-1.29) (I2=45.9%, p=0.116). Compared to combustible cigarette only users, pooled OR of stroke occurrence in both of e-cigarette and combustible cigarette users was 1.39 (95% CI: 1.19-1.64) (I2=5.6%, p=0.303). In addition, pooled OR in currently e-cigarette only users who were formerly combustible cigarette only users was 1.59 (95% CI: 1.22-2.07) (I2=0.0%, p=0.989).
Conclusions:
The role of e-cigarette use in the development of stroke is inconclusive, due to the strong effect of prior tobacco use as a risk factor for stroke in the included studies.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Statistical Methods for Analyzing Epidemiological Data
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Stress Prevention and Stress Management Techniques IV